Mei-Jung Lin

Title: Innovations of Mei-Jung Lin in Pharmaceutical Chemistry

Introduction

Mei-Jung Lin is a notable inventor based in Sinying, Taiwan. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on aporphine derivatives and their applications in treating various diseases. With a total of two patents to her name, her research focuses on developing novel compounds that can address critical health issues.

Latest Patents

Mei-Jung Lin's latest patents include "Pharmaceutically acceptable salts of aporphine derivatives and carboxyl group-containing agents and methods for preparing the same." This invention discloses novel pharmaceutically acceptable salts of aporphine compounds and carboxyl-group containing agents. The methods for preparing these salts are also outlined, which are suitable for treating and preventing hyperglycemic diseases and several oxidative stress-related diseases. Another significant patent is "Aporphine derivatives and pharmaceutical use thereof," which reveals novel aporphine derivatives that can be utilized for treating oxidative stress-induced diseases such as cardiovascular disease, diabetes, aging, Alzheimer's disease, kidney disease, cancer, and brain ischemic disease.

Career Highlights

Mei-Jung Lin is currently associated with Standard Chem. & Pharm. Co., Ltd., where she continues her research and development efforts. Her work has garnered attention for its potential impact on public health, particularly in the realm of chronic diseases.

Collaborations

Some of her notable coworkers include Chin-Tsai Fan and Cheng-Shun Lai, who contribute to her research endeavors and collaborative projects.

Conclusion

Mei-Jung Lin's innovative work in pharmaceutical chemistry exemplifies the importance of research in developing new treatments for serious health conditions. Her contributions through her patents highlight her commitment to advancing medical science and improving patient outcomes.